{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:30:52Z","timestamp":1787725852486,"version":"build-2784847793"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403182"],"award-info":[{"award-number":["82403182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03371-z","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:53:24Z","timestamp":1762523604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["KDM3B suppresses castration-resistance prostate cancer cell proliferation by promoting PTEN expression"],"prefix":"10.1186","volume":"30","author":[{"given":"Pengfei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"1","key":"3371_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3371_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3371_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111455","author":"S Sur","year":"2019","unstructured":"Sur S, Steele R, Shi X, Ray RB. miRNA-29b inhibits prostate tumor growth and induces apoptosis by increasing Bim expression. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8111455.","journal-title":"Cells"},{"issue":"6","key":"3371_CR4","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/cncr.23304","volume":"112","author":"RW Ross","year":"2008","unstructured":"Ross RW, Xie W, Regan MM, Pomerantz M, Nakabayashi M, Daskivich TJ, et al. Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect. Cancer. 2008;112(6):1247\u201353.","journal-title":"Cancer"},{"issue":"2","key":"3371_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/cncr.31846","volume":"125","author":"SJ Curry","year":"2019","unstructured":"Curry SJ, Krist AH, Owens DK. Annual report to the nation on the status of cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer. 2019;125(2):317\u20138.","journal-title":"Cancer"},{"issue":"2","key":"3371_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2014;65(2):467\u201379.","journal-title":"Eur Urol"},{"issue":"5","key":"3371_CR7","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3892\/or.2017.5972","volume":"38","author":"M Nowacka-Zawisza","year":"2017","unstructured":"Nowacka-Zawisza M, Wisnik E. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (review). Oncol Rep. 2017;38(5):2587\u201396.","journal-title":"Oncol Rep"},{"issue":"3","key":"3371_CR8","first-page":"228","volume":"48","author":"NR Perdana","year":"2016","unstructured":"Perdana NR, Mochtar CA, Umbas R, Hamid AR. The risk factors of Prostate cancer and its prevention: a literature review. Acta Med Indones. 2016;48(3):228\u201338.","journal-title":"Acta Med Indones"},{"key":"3371_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.12659\/MSM.912294","volume":"25","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yan L, Yao W, Chen K, Xu H, Ye Z. Integrated analysis of genetic abnormalities of the histone lysine methyltransferases in prostate cancer. Med Sci Monit. 2019;25:193\u2013239.","journal-title":"Med Sci Monit"},{"key":"3371_CR10","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01503","volume":"2","author":"JE Lee","year":"2013","unstructured":"Lee JE, Wang C, Xu S, Cho YW, Wang L, Feng X, et al. H3k4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. Elife. 2013;2:e01503.","journal-title":"Elife"},{"issue":"17","key":"3371_CR11","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1101\/gad.303768.117","volume":"31","author":"CC Sze","year":"2017","unstructured":"Sze CC, Cao K, Collings CK, Marshall SA, Rendleman EJ, Ozark PA, et al. Histone H3K4 methylation-dependent and -independent functions of Set1A\/COMPASS in embryonic stem cell self-renewal and differentiation. Genes Dev. 2017;31(17):1732\u20137.","journal-title":"Genes Dev"},{"issue":"42","key":"3371_CR12","doi-asserted-by":"publisher","first-page":"11871","DOI":"10.1073\/pnas.1606857113","volume":"113","author":"C Wang","year":"2016","unstructured":"Wang C, Lee JE, Lai B, Macfarlan TS, Xu S, Zhuang L, et al. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition. Proc Natl Acad Sci U S A. 2016;113(42):11871\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"3371_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41594-019-0298-7","volume":"26","author":"D Husmann","year":"2019","unstructured":"Husmann D, Gozani O. Histone lysine methyltransferases in biology and disease. Nat Struct Mol Biol. 2019;26(10):880\u20139.","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"3371_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.57","volume":"49","author":"H Shen","year":"2017","unstructured":"Shen H, Xu W, Lan F. Histone lysine demethylases in mammalian embryonic development. Exp Mol Med. 2017;49(4):e325.","journal-title":"Exp Mol Med"},{"key":"3371_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33375","author":"J Sterling","year":"2020","unstructured":"Sterling J, Menezes SV, Abbassi RH, Munoz L. Histone lysine demethylases and their functions in cancer. Int J Cancer. 2020. https:\/\/doi.org\/10.1002\/ijc.33375.","journal-title":"Int J Cancer"},{"issue":"10","key":"3371_CR16","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41388-019-1116-8","volume":"39","author":"H Sarac","year":"2020","unstructured":"Sarac H, Morova T, Pires E, McCullagh J, Kaplan A, Cingoz A, et al. Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer. Oncogene. 2020;39(10):2187\u2013201.","journal-title":"Oncogene"},{"key":"3371_CR17","doi-asserted-by":"publisher","first-page":"1116424","DOI":"10.3389\/fcell.2023.1116424","volume":"11","author":"VM Metzler","year":"2023","unstructured":"Metzler VM, de Brot S, Haigh DB, Woodcock CL, Lothion-Roy J, Harris AE, et al. The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer. Front Cell Dev Biol. 2023;11:1116424.","journal-title":"Front Cell Dev Biol"},{"key":"3371_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114077","volume":"158","author":"L Duan","year":"2023","unstructured":"Duan L, Chen YA, Liang Y, Chen Z, Lu J, Fang Y, et al. Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancer. Biomed Pharmacother. 2023;158:114077.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"3371_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.bbrc.2018.11.179","volume":"508","author":"MJ An","year":"2019","unstructured":"An MJ, Kim DH, Kim CH, Kim M, Rhee S, Seo SB, et al. Histone demethylase KDM3B regulates the transcriptional network of cell-cycle genes in hepatocarcinoma HepG2 cells. Biochem Biophys Res Commun. 2019;508(2):576\u201382.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3371_CR20","doi-asserted-by":"publisher","first-page":"R155","DOI":"10.1530\/ERC-12-0285","volume":"20","author":"X Wu","year":"2013","unstructured":"Wu X, Gong S, Roy-Burman P, Lee P, Culig Z. Current mouse and cell models in prostate cancer research. Endocr Relat Cancer. 2013;20(4):R155-170.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"3371_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12943-018-0803-3","volume":"17","author":"N Haddadi","year":"2018","unstructured":"Haddadi N, Lin Y, Travis G, Simpson AM, Nassif NT, McGowan EM. PTEN\/PTENP1: \u201cregulating the regulator of RTK-dependent PI3K\/Akt signalling\u201d, new targets for cancer therapy. Mol Cancer. 2018;17(1):37.","journal-title":"Mol Cancer"},{"issue":"2","key":"3371_CR22","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1096\/fj.201900677R","volume":"34","author":"MG Strainic","year":"2020","unstructured":"Strainic MG, Pohlmann E, Valley CC, Sammeta A, Hussain W, Lidke DS, et al. RTK signaling requires C3ar1\/C5ar1 and IL-6R joint signaling to repress dominant PTEN, SOCS1\/3 and PHLPP restraint. FASEB J. 2020;34(2):2105\u201325.","journal-title":"FASEB J"},{"issue":"7406","key":"3371_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012;487(7406):239\u201343.","journal-title":"Nature"},{"issue":"2","key":"3371_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nsmb.2209","volume":"19","author":"V Migliori","year":"2012","unstructured":"Migliori V, Muller J, Phalke S, Low D, Bezzi M, Mok WC, et al. Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance. Nat Struct Mol Biol. 2012;19(2):136\u201344.","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"3371_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2012.11.006","volume":"48","author":"JC Black","year":"2012","unstructured":"Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell. 2012;48(4):491\u2013507.","journal-title":"Mol Cell"},{"issue":"7","key":"3371_CR26","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","volume":"119","author":"Y Shi","year":"2004","unstructured":"Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119(7):941\u201353.","journal-title":"Cell"},{"issue":"12","key":"3371_CR27","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.celrep.2018.08.052","volume":"24","author":"C Bouchard","year":"2018","unstructured":"Bouchard C, Sahu P, Meixner M, Notzold RR, Rust MB, Kremmer E, et al. Genomic location of PRMT6-dependent H3R2 methylation is linked to the transcriptional outcome of associated genes. Cell Rep. 2018;24(12):3339\u201352.","journal-title":"Cell Rep"},{"issue":"1","key":"3371_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/onc.2016.186","volume":"36","author":"C Cao","year":"2017","unstructured":"Cao C, Vasilatos SN, Bhargava R, Fine JL, Oesterreich S, Davidson NE, et al. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression. Oncogene. 2017;36(1):133\u201345.","journal-title":"Oncogene"},{"issue":"3","key":"3371_CR29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ijc.25349","volume":"128","author":"S Hayami","year":"2011","unstructured":"Hayami S, Kelly JD, Cho HS, Yoshimatsu M, Unoki M, Tsunoda T, et al. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer. 2011;128(3):574\u201386.","journal-title":"Int J Cancer"},{"key":"3371_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aau2922","author":"A Augert","year":"2019","unstructured":"Augert A, Eastwood E, Ibrahim AH, Wu N, Grunblatt E, Basom R, et al. Targeting notch activation in small cell lung cancer through LSD1 inhibition. Sci Signal. 2019. https:\/\/doi.org\/10.1126\/scisignal.aau2922.","journal-title":"Sci Signal"},{"issue":"3","key":"3371_CR31","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/1878-0261.12174","volume":"12","author":"M Staberg","year":"2018","unstructured":"Staberg M, Rasmussen RD, Michaelsen SR, Pedersen H, Jensen KE, Villingshoj M, et al. Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B. Mol Oncol. 2018;12(3):406\u201320.","journal-title":"Mol Oncol"},{"key":"3371_CR32","doi-asserted-by":"publisher","first-page":"15146","DOI":"10.1038\/ncomms15146","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Yu B, Deng P, Cheng Y, Yu Y, Kevork K, et al. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt\/beta-catenin signalling. Nat Commun. 2017;8:15146.","journal-title":"Nat Commun"},{"issue":"10","key":"3371_CR33","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/ijc.33375","volume":"148","author":"J Sterling","year":"2021","unstructured":"Sterling J, Menezes SV, Abbassi RH, Munoz L. Histone lysine demethylases and their functions in cancer. Int J Cancer. 2021;148(10):2375\u201388.","journal-title":"Int J Cancer"},{"key":"3371_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111785","author":"CY Lin","year":"2019","unstructured":"Lin CY, Wang BJ, Chen BC, Tseng JC, Jiang SS, Tsai KK, et al. Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11111785.","journal-title":"Cancers"},{"issue":"11","key":"3371_CR35","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1002\/ijc.31843","volume":"143","author":"KH Lee","year":"2018","unstructured":"Lee KH, Hong S, Kang M, Jeong CW, Ku JH, Kim HH, et al. Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer. Int J Cancer. 2018;143(11):2849\u201361.","journal-title":"Int J Cancer"},{"issue":"1","key":"3371_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41419-020-03354-4","volume":"12","author":"Z Cao","year":"2021","unstructured":"Cao Z, Shi X, Tian F, Fang Y, Wu JB, Mrdenovic S, et al. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer. Cell Death Dis. 2021;12(1):2.","journal-title":"Cell Death Dis"},{"issue":"5308","key":"3371_CR37","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275(5308):1943\u20137.","journal-title":"Science"},{"issue":"4","key":"3371_CR38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng0497-356","volume":"15","author":"PA Steck","year":"1997","unstructured":"Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997;15(4):356\u201362.","journal-title":"Nat Genet"},{"issue":"1","key":"3371_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","volume":"95","author":"V Stambolic","year":"1998","unstructured":"Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, et al. Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998;95(1):29\u201339.","journal-title":"Cell"},{"issue":"3","key":"3371_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/CS20160026","volume":"131","author":"HM Wise","year":"2017","unstructured":"Wise HM, Hermida MA, Leslie NR. Prostate cancer, PI3K, PTEN and prognosis. Clin Sci. 2017;131(3):197\u2013210.","journal-title":"Clin Sci"},{"issue":"5","key":"3371_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41585-021-00442-8","volume":"18","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, et al. Epidemiology and genomics of prostate cancer in Asian men. Nat Rev Urol. 2021;18(5):282\u2013301.","journal-title":"Nat Rev Urol"},{"key":"3371_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175949","author":"B Zhang","year":"2024","unstructured":"Zhang B, Liu M, Mai F, Li X, Wang W, Huang Q, et al. Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI175949.","journal-title":"J Clin Invest"},{"issue":"1","key":"3371_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ccell.2020.10.012","volume":"39","author":"I Guccini","year":"2021","unstructured":"Guccini I, Revandkar A, D\u2019Ambrosio M, Colucci M, Pasquini E, Mosole S, et al. Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis. Cancer Cell. 2021;39(1):68\u201382.","journal-title":"Cancer Cell"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03371-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03371-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03371-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:53:25Z","timestamp":1762523605000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03371-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3371"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03371-z","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethic committee of Tongji Hospital, School of Medicine, Tongji University (SBKT-2024\u2013103). Each participate volunteered to join and signed the informed consent form. The study conformed to the provisions of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publish this article. All patients understood the purpose of the study, voluntarily provided specimens and consented to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1090"}}